Duchenne Muscular Dystrophy clinical trials at UCSF
2 in progress, 1 open to eligible people

• Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy

  open to eligible males ages 5 years and up

  This study is a long-term study of ataluren in participants with nonsense mutation Duchenne muscular dystrophy.

  Oakland, California and other locations

• Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)

  Sorry, in progress, not accepting new patients

  This is a Phase 2, open-label, single arm trial of pamrevlumab (FG-3019) to estimate pamrevlumab's safety and efficacy in non-ambulatory subjects with DMD.

  San Francisco, California and other locations

Last updated: August 1, 2019